Cargando…

Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma

OBJECTIVES: To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA). METHODS: Forty-nine patients with EEA underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Liu, Xinyu, Wang, Xiaoqi, Lin, Chengyu, Qi, Yafei, Chen, Bo, Zhou, Hailong, Wu, Qiaoling, Ren, Jing, Zhao, Jia, Yang, Junjun, Xiang, Yang, He, Yonglan, Jin, Zhengyu, Xue, Huadan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665952/
https://www.ncbi.nlm.nih.gov/pubmed/34894294
http://dx.doi.org/10.1186/s13244-021-01126-y
_version_ 1784614111444729856
author Li, Yuan
Liu, Xinyu
Wang, Xiaoqi
Lin, Chengyu
Qi, Yafei
Chen, Bo
Zhou, Hailong
Wu, Qiaoling
Ren, Jing
Zhao, Jia
Yang, Junjun
Xiang, Yang
He, Yonglan
Jin, Zhengyu
Xue, Huadan
author_facet Li, Yuan
Liu, Xinyu
Wang, Xiaoqi
Lin, Chengyu
Qi, Yafei
Chen, Bo
Zhou, Hailong
Wu, Qiaoling
Ren, Jing
Zhao, Jia
Yang, Junjun
Xiang, Yang
He, Yonglan
Jin, Zhengyu
Xue, Huadan
author_sort Li, Yuan
collection PubMed
description OBJECTIVES: To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA). METHODS: Forty-nine patients with EEA underwent T1-weighted imaging, T2-weighted imaging, 3D APTw imaging, and diffusion-weighted imaging at 3 T MRI. Image quality and measurement confidence of APTw images were evaluated on a 5-point Likert scale. APTw and apparent diffusion coefficient (ADC) values were calculated and compared between the dMMR and pMMR groups and among the three EEA histologic grades based on the Federation of Gynecology and Obstetrics (FIGO) grading system criteria. Student’s t-test, analysis of variance with Scheffe post hoc test, and receiver operating characteristic analysis were performed. Statistical significance was set at p < 0.05. RESULTS: Thirty-five EEA patients (9 with dMMR tumors and 26 with pMMR tumors) with good image quality were enrolled in quantitative analysis. APTw values were significantly higher in the dMMR group than in the pMMR group (3.2 ± 0.3% and 2.8 ± 0.5%, respectively; p = 0.019). ADC values of the dMMR and pMMR groups were 0.874 ± 0.104 × 10(−3) mm(2)/s and 0.903 ± 0.100 × 10(−3) mm(2)/s, respectively. No significant between-group difference was noted (p = 0.476). No statistically significant differences were observed in APTw values or ADC values among the three histologic grades (p = 0.766 and p = 0.295, respectively). CONCLUSIONS: APTw values may be used as potential imaging markers to differentiate dMMR from pMMR tumors in EEA.
format Online
Article
Text
id pubmed-8665952
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-86659522021-12-27 Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma Li, Yuan Liu, Xinyu Wang, Xiaoqi Lin, Chengyu Qi, Yafei Chen, Bo Zhou, Hailong Wu, Qiaoling Ren, Jing Zhao, Jia Yang, Junjun Xiang, Yang He, Yonglan Jin, Zhengyu Xue, Huadan Insights Imaging Original Article OBJECTIVES: To investigate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging to differentiate mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors in endometrioid endometrial adenocarcinoma (EEA). METHODS: Forty-nine patients with EEA underwent T1-weighted imaging, T2-weighted imaging, 3D APTw imaging, and diffusion-weighted imaging at 3 T MRI. Image quality and measurement confidence of APTw images were evaluated on a 5-point Likert scale. APTw and apparent diffusion coefficient (ADC) values were calculated and compared between the dMMR and pMMR groups and among the three EEA histologic grades based on the Federation of Gynecology and Obstetrics (FIGO) grading system criteria. Student’s t-test, analysis of variance with Scheffe post hoc test, and receiver operating characteristic analysis were performed. Statistical significance was set at p < 0.05. RESULTS: Thirty-five EEA patients (9 with dMMR tumors and 26 with pMMR tumors) with good image quality were enrolled in quantitative analysis. APTw values were significantly higher in the dMMR group than in the pMMR group (3.2 ± 0.3% and 2.8 ± 0.5%, respectively; p = 0.019). ADC values of the dMMR and pMMR groups were 0.874 ± 0.104 × 10(−3) mm(2)/s and 0.903 ± 0.100 × 10(−3) mm(2)/s, respectively. No significant between-group difference was noted (p = 0.476). No statistically significant differences were observed in APTw values or ADC values among the three histologic grades (p = 0.766 and p = 0.295, respectively). CONCLUSIONS: APTw values may be used as potential imaging markers to differentiate dMMR from pMMR tumors in EEA. Springer International Publishing 2021-12-11 /pmc/articles/PMC8665952/ /pubmed/34894294 http://dx.doi.org/10.1186/s13244-021-01126-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Li, Yuan
Liu, Xinyu
Wang, Xiaoqi
Lin, Chengyu
Qi, Yafei
Chen, Bo
Zhou, Hailong
Wu, Qiaoling
Ren, Jing
Zhao, Jia
Yang, Junjun
Xiang, Yang
He, Yonglan
Jin, Zhengyu
Xue, Huadan
Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
title Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
title_full Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
title_fullStr Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
title_full_unstemmed Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
title_short Using amide proton transfer-weighted MRI to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
title_sort using amide proton transfer-weighted mri to non-invasively differentiate mismatch repair deficient and proficient tumors in endometrioid endometrial adenocarcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665952/
https://www.ncbi.nlm.nih.gov/pubmed/34894294
http://dx.doi.org/10.1186/s13244-021-01126-y
work_keys_str_mv AT liyuan usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT liuxinyu usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT wangxiaoqi usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT linchengyu usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT qiyafei usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT chenbo usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT zhouhailong usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT wuqiaoling usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT renjing usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT zhaojia usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT yangjunjun usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT xiangyang usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT heyonglan usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT jinzhengyu usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma
AT xuehuadan usingamideprotontransferweightedmritononinvasivelydifferentiatemismatchrepairdeficientandproficienttumorsinendometrioidendometrialadenocarcinoma